5 Mar 2014

BioLineRx to Present at the Annual ROTH Growth Stock Conference

a-
A+
Customize font size:
Share:
BioLineRx (NASDAQ: BLRX; TASE: BLRX), a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today that its Chief Executive Officer, Kinneret Savitsky, Ph.D., and its Chief Financial and Operating Officer, Philip Serlin, will be presenting at the 26th Annual ROTH Growth Stock Conference being held at the Ritz Carlton in Dana Point, CA.
 
The BioLineRx presentation is scheduled to start at 09:30 a.m. PST (12:30 p.m. EST) on Monday, March 10, 2014. A live audio webcast of the presentation will be available online at BioLineRx's investor web page. An archive of the event will also be available for those unable to listen live.